Institutional investors purchased a net $13.7 million shares of OPK during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 19.55% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRIVATE CAPITAL ADVISORS, INC. Bought 137.0 Thousand shares of OPKO Health Inc
MIZUHO SECURITIES USA, INC. Bought 50.0 Thousand shares of OPKO Health Inc
QUANTBOT TECHNOLOGIES LLC Bought 24.6 Thousand shares of OPKO Health Inc